Infectious Disease· Topic 7.5 Lower respiratory tract infections· 7.5.8

Mycoplasma pneumoniae infection

Mycoplasma pneumoniae is a cell-wall-deficient atypical bacterium and a classic cause of walking pneumonia in young, previously healthy people in close-contact settings, notable for a gradual onset, cough out of proportion to exam and imaging findings, beta-lactam resistance, and a distinctive set of extrapulmonary manifestations.

9 min read14 practice questions7 key factsSubscriber article
  • Topic review
    The full article, organized the way the exam asks it.
  • ABIM-format MCQs
    Vignettes with an explanation for every wrong answer.
  • Key facts
    The numbers and thresholds worth memorizing, up front.
  • AI tutor
    MedBrain answers the question you're stuck on.

What this article covers

  • Overview

    A cell-wall-deficient atypical bacterium causing "walking pneumonia": one of the smallest organisms capable of extracellular replication, spread by droplet inhalation, and a classic cause of atypical…

  • Epidemiology

    Primarily affects previously healthy young people, most frequently patients under about 30 years old, including school-age children.

  • Risk factors

    Age under 30 years, the demographic in which most clinically recognized infection occurs.

  • Pathophysiology

    Absence of a cell wall is the central mechanism: no peptidoglycan target means beta-lactam antibiotics, which act on cell-wall synthesis, are ineffective.

  • Clinical features

    Gradual, insidious onset over days, unlike the abrupt onset of typical bacterial pneumonia: headache, malaise, sore throat, and low-grade fever typically precede the pulmonary symptoms.

  • Differential diagnosis

    Legionella pneumonia: the most dangerous atypical mimic; distinguished by gastrointestinal symptoms (often diarrhea), hyponatremia, elevated liver enzymes, relative bradycardia, a positive urinary…

  • Diagnosis

    There is no validated formal clinical diagnostic criteria score or organism-specific severity grading; the diagnosis is confirmed by identifying the organism, most reliably by PCR of a respiratory…

  • Management

    First, start empiric atypical-coverage therapy as soon as clinically suspected, without waiting for confirmatory testing, since beta-lactams will not work: for an outpatient without risk factors…

  • Complications

    Cold agglutinin-mediated hemolytic anemia, the most common extrapulmonary complication, appearing late in the illness.

  • Prognosis

    Most infections are self-limited and mild ("walking pneumonia"), and most patients are managed as outpatients without hospitalization.

  • Prevention

    No vaccine exists against Mycoplasma pneumoniae; prevention relies on limiting transmission and using antibiotics appropriately.

Read the whole article

Subscribing to Internal Medicine opens every article, the full question bank and MedBrain, on the web, iPhone and Android.